At Baerenkraft, we fast-track the development of treatments for patients with limited options—leveraging AI and proven science to accelerate the movement of medicines to the clinic.
PipelineWe specialize in supporting early-phase clinical development across high-impact therapeutic areas. Our experience spans complex disease landscapes where precision, speed, and adaptability are critical. By focusing on immunology, oncology, and metabolic disorders, we help bring novel treatments to patients faster.
About
Our work in immunology & inflammation addresses complex disorders with high unmet need, such as immunoinflammation. While this is a focused area of development, we are advancing select candidates with strong scientific and translational rationale.
We are developing oncology candidates for multiple forms of cancer, targeting high-burden tumors with urgent therapeutic gaps. Our focus is on well-characterized molecular pathways that offer potential for meaningful patient outcomes.
We are tackling metabolic diseases like obesity and Type 2 diabetes by targeting key hormonal and cellular pathways. Our goal is to develop treatments that align with real-world needs for chronic disease management.
Globally, millions of patients lack effective treatment options. By focusing our efforts on areas with the greatest clinical gaps, we aim to accelerate innovation where it is needed most – improving lives and advancing care.
Contact
We strive to exploit novel technologies combined with proven science to deliver powerful new therapies. Our scientists are advancing research every day to move treatments closer to patients in need.
Pipeline
.svg)